Tecentriq Atezolizumab Injection For Intravenous Use 1200 MG Trademark Details
Word Mark | Tecentriq Atezolizumab Injection for Intravenous Use 1200 Mg |
---|---|
Status | Alive 630 — New Application - Record Initialized Not Assigned to Examiner |
Serial Number | 87178937 |
---|---|
Status Date | Tuesday, September 27, 2016 |
Filing Date | Tuesday, September 27, 2016 |
Correspondent
GENENTECH, INC.
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080-4990
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080-4990
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Disclaimer with Predetermined Text | "Atezolizumab Injection for Intravenous Use 1200 Mg" |
Description of Mark | The mark consists of THE WORD TECENTRIQ WITH ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG UNDER IT. THE FIRST T IN TECENTRIQ HAS THREE ARROWS POINTING INWARDS IN A CIRCLE ABOVE IT IN THE UPPER LEFT HAND CORNER. |
Goods & Services | Providing online information services, namely, prescription drug information |
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, September 27, 2016 |
First Use Anywhere | Wednesday, May 18, 2016 |
First Use In Commerce | Wednesday, May 18, 2016 |
Primary Code | 042 |
Trademark Timeline
-
May 18 2016First use anywhere for the mark
-
May 18 2016First use in commerce for the mark
-
Sep 21 2016Trademark application filed with USPTO
-
Sep 24 2016New Application Entered In Tram
-
Sep 27 2016New Application Office Supplied Data Entered In Tram
-
Sep 28 2016Notice of Design Search Code E-Mailed